Andere talen Marizyme, Inc.

Aandelen

GBSX

US5703721028

Beurs gesloten - OTC Markets Andere beurzen 20:20:59 20-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0541 ^USD	-41,83%		0,00%	-45,95%

28/05	Marizyme, Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
13/05	Marizyme, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Marizyme, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/05
Marizyme, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/05
Marizyme : Secures FDA 510(k) Clearance for Controlled Room Temperature storage DuraGraft® - Form 8-K	06/05
Marizyme, Inc. Secures FDA 510(k) Clearance for Controlled Room Temperature Storage DuraGraft	06/05
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™	16/04
Marizyme, Inc. Announces Resignation of Julie Kampf from the Board of Directors	06/02
Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Marizyme CEO Delivers Business Update	23-10-23
Marizyme CEO Delivers Business Update	23-10-23
OTC Active Stocks Watchlist (EPAZ, MRZM, GCEI, TMGI)	09-10-23
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™	06-10-23
Marizyme, Inc. Announces FDA Clearance for Product, Duragraft	06-10-23
Marizyme, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	18-08-23
MARIZYME, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	24-05-23
Marizyme, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Marizyme, Inc. announced a financing transaction	15-05-23
MARIZYME INC : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	10-05-23
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products	10-05-23
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products	10-05-23
Marizyme, Inc. Announces IP Developments for DuraGraft and its Pipeline of Products	10-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Marizyme, Inc.

Aandelen

GBSX

US5703721028

Andere talen

Filters